Our cloud query

George Miller, FierceBiotech ITConsider FierceBiotech IT your front line for cloud research.

For our upcoming special report on cloud computing, which clouds do you want to know about, and what do you need to know about them? We are soliciting such basic information as infrastructure details and pricing, but there's a lot more to clouds than that. Tell us in general terms about your application requirements and concerns, and we'll seek the details from the cloud service providers.

For your queries received this week and next, we'll either include our findings in the special report, to run August 24, or reply to you individually if your request falls outside the scope of the report.

Please reply to me directly at [email protected]


Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.